Results 21 to 30 of about 190,349 (50)

Seronegative Paraneoplastic Opsoclonus–Myoclonus–Ataxia Syndrome Secondary to Low Volume Endocrine-Sensitive Malignancy of Likely Breast Origin

Current Oncology
A 51-year-old female presented to the emergency department with vertigo, visual disturbances, involuntary rapid repetitive eye movements, incoordination, and imbalance.
Geraint Berger, Caitlin Jackson-Tarlton, Daniel Rayson, Alexander Silver, Mark Walsh, Ashley Drohan   +5 more
doaj   +1 more source

New Trends in Thyroid Malignancy: Minimally Invasive Thermal Ablation Percutaneous Techniques for T1 Papillary Thyroid Carcinomas

Current Oncology
During the late 1990s, thyroid nodule management strongly improved with the development of high-frequency ultrasound (HFUS) and US-guided percutaneous procedures [...]
Pierre Yves Marcy
doaj   +1 more source

A Review on the Evolving Role of Radiation Therapy in the Treatment of Locally Advanced Rectal Cancer

Current Oncology
Treatment of locally advanced rectal cancer (LARC), clinical stages II–III, typically involves multimodal treatment options. Over the past decade, the role of radiation therapy as a neoadjuvant treatment for LARC has evolved and is currently a part of ...
Zeinab Dandash, Tala Mobayed, Sally Temraz, Ali Shamseddine, Samer Doughan, Samer Deeba, Zeina Ayoub, Toufic Eid, Bassem Youssef, Lara Hilal   +9 more
doaj   +1 more source

Treatment Disparities, Heterogeneities, and Barriers to Access for Patients with Hormone Receptor-Positive, Human Epidermal Growth Factor Receptor 2-Negative Metastatic Breast Cancer: A National Survey from Brazil

Current Oncology
Breast cancer (BC) is the most common malignancy among Brazilian women, with a high percentage of the cases diagnosed at advanced or metastatic stages (mBC). In Brazil, where 75% of the population depends on the resource-limited public health system (SUS)
Heloisa Resende, Vinícius de Q. Aguiar, Nataline F. de A. Santos, João Vitor Siqueira Jardim, André Ornelas   +4 more
doaj   +1 more source

The Relation Between Post-Operative Surgical Site Infection and Time to Start Adjuvant Treatment in Ovarian and Uterine Cancers

Current Oncology
Surgical site infections (SSIs) occur in 10–15% of patients and are linked to up to 29% of delays in starting adjuvant treatment. This study assessed the association between SSIs in patients with ovarian and uterine cancer and their impact on time to ...
Karlijn M. C. Cornel, Julie My Van Nguyen, Lilian T. Gien, Allan Covens, Danielle Vicus   +4 more
doaj   +1 more source

Recent Advances in the Management of EGFR-Mutated Advanced Non-Small Cell Lung Cancer—A Narrative Review

Current Oncology
The treatment landscape for EGFR-mutated metastatic non-small cell lung cancer (mNSCLC) has evolved significantly with multiple combination regimens demonstrating superiority over single agent Osimertinib over the past two years.
Prabhat Gautam Roy, Davida Reingold, Neha Pathak, Saurav Verma, Aarushi Gupta, Nicholas Meti, Consolacion Molto, Prabhat Singh Malik, Geordie Linford, Abhenil Mittal   +9 more
doaj   +1 more source

Incidence of Venous Thromboembolism in Newly Diagnosed Glioblastoma and Associated Risk Factors: A Retrospective Chart Review

Current Oncology
This was a single-centre retrospective cohort study of patients diagnosed with glioblastoma (GB) at the Juravinski Cancer Centre (JCC). The charts of 528 patients diagnosed with GB at the JCC from an 8-year period from 1 January 2013, to 31 December 2020,
Duaa Binjabal, Nasser Al Majarafi, Gregory R. Pond, Hal Hirte   +3 more
doaj   +1 more source

Extended Survival with Pancreatic Carcinosarcoma: A Case Report and Literature Review

Current Oncology
Pancreatic carcinosarcoma is a rare and aggressive malignancy that can mimic pancreatic adenocarcinomas in presentation but often has different disease biology and different responses to conventional treatment for pancreatic adenocarcinoma.
Tian Xiao, Claire Browne, Morgan Black, Celia Marginean, Elena Tsvetkova   +4 more
doaj   +1 more source

Predictors of Surgical Complications and Survival in Pediatric Wilms’ Tumor: A 20-Year Retrospective Study from Two Thai Centers

Current Oncology
(1) Background: Wilms’ tumor (WT) is the most common pediatric renal malignancy. Although survival outcomes have improved with multimodal therapy, the optimal sequence of surgery and chemotherapy remains debated, particularly in resource-limited settings.
Wison Laochareonsuk, Mongkol Laohapansang, Monawat Ngerncham, Surasak Sangkhathat   +3 more
doaj   +1 more source

Management and outcomes of non–small cell lung cancer patients with rapid progression under second‐or‐more‐line immune checkpoint inhibitors: ERORECI study (GFPC 2016‐04)

Cancer Medicine, 2020
Background Immune checkpoint inhibitors (ICIs) have been approved as second‐line therapy for advanced non–small cell lung cancers (NSCLCs) progressing after platinum‐based chemotherapy.
Alain Vergnenegre, Margaux Geier, Florian Guisier, Regine Lamy, Bénédicte Comet, Gwenaelle Le Garff, Pascal Do, Henri Janicot, Hugues Morel, Chantal Decroisette, Michel Andre, Lionel Falchero, Nicolas Paleiron, Isabelle Monnet, the GFPC Team   +14 more
doaj   +1 more source